SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study‐II blood centers in Brazil
10 references·16 citing·36 second hop
Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study‐II blood centers in Brazil (2011)Human immunodeficiency virus prevalence, …Screening donated blood for transfusion-transmissible infections, recommendations (2011)Screening donated blood for t…The risk of transfusion‐transmitted infections in sub‐Saharan Africa (2009)The risk of transfusion‐trans…Relative safety of first‐time volunteer and replacement donors in West Africa (2009)Relative safety of first‐time…Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Infectivity of human immunode…Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (2005)Residual risk of transfusion …Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first‐time blood donors in São Paulo, Brazil (2005)Prevalence, incidence, and re…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating…Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. (2003)Incidence and estimated rates…Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Current prevalence and incide…Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Trends in Incidence and Preva…Prevalence and Association of Transfusion Transmitted Infections with ABO and Rh Blood Groups among Blood Donors in the Western Region of Saudi Arabia: A 7-Year Retrospective Analysis (2022)Prevalence and Association of…Seroprevalence of Transfusion-Transmitted Infections among Voluntary and Replacement Blood Donors at the Peshawar Regional Blood Centre, Khyber Pakhtunkhwa, Pakistan (2021)Seroprevalence of Transfusion…Sero-prevalence ABO and Rh blood groups and their associated Transfusion-Transmissible Infections among Blood Donors in the Central Region of Saudi Arabia (2020)Sero-prevalence ABO and Rh bl…Prevalence and Association of Transfusion Transmitted Infections with ABO and Rh Blood Groups among Blood Donors at the National Blood Bank, Amman, Jordan (2020)Prevalence and Association of…Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil (2017)Residual risk of transmission…The infectious risks in blood transfusion as of today – A no black and white situation (2016)The infectious risks in blood…Estimating the residual risk for HIV , HCV and HBV in different types of platelet concentrates in Germany (2014)Estimating the residual risk …Changes in the prevalence, incidence and residual risk for HIV and hepatitis C virus in Southern Brazilian blood donors since the implementation of NAT screening (2014)Changes in the prevalence, in…Undisclosed human immunodeficiency virus risk factors identified through a computer‐based questionnaire program among blood donors in B razil (2013)Undisclosed human immunodefic…Human immunodeficiency virus transfusion transmission despite nucleic acid testing (2013)Human immunodeficiency virus …Can family or replacement blood donors become regular volunteer donors? (2013)Can family or replacement blo…The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): Twenty Years of Research to Advance Blood Product Safety and Availability (2012)The National Heart, Lung, and…Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010 (2012)Residual risk of transfusion-…Relationship between social capital and test seeking among blood donors in Brazil (2012)Relationship between social c…Prevalence, incidence, and residual risks for transfusion‐transmitted human immunodeficiency virus T ypes 1 and 2 infection among C hinese blood donors (2012)Prevalence, incidence, and re…Analysis of donor deferral at three blood centers in Brazil (2012)Analysis of donor deferral at…The Risk of Transfusion-Transmitted Viral Infections (1996)The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007 (2009)Seroprevalence and Trends in Transfusion Transmitted Infections Among Blood Donors in a University Hospital Blood Bank: A 5 Year Study (2010)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations (2003)Current risk for transfusion transmitted infections (2007)Reducing the risk of transfusion‐transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006 (2007)Informative Dorfman Screening (2011)Meta-analysis of Observational Studies in Epidemiology A Proposal for Reporting (2000)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique (2011)The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood (2011)Transfusion transmitted infections – A retrospective analysis from the National Blood Transfusion Service in Eritrea (2011)Screening for viral markers in volunteer and replacement blood donors in West Africa (2001)Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings (2005)Characteristics of blood donors and donated blood in sub‐Saharan Francophone Africa (2009)Seroprevalence and incidence of transfusion‐transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa (2011)External Financial Aid to Blood Transfusion Services in Sub-Saharan Africa: A Need for Reflection (2012)The blood supply in Sub-Saharan Africa: Needs, challenges, and solutions (2013)Human immunodeficiency virus type 1 ‐infected blood donors:behavioral characteristics and reasons for donation (1991)Human immunodeficiency virus test‐seeking motivation in blood donors, São Paulo, Brazil (2006)Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS‐II study, 2007 to 2008 (2009)Family donors are critical and legitimate in developing countries (2015)Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States (2004)Safety of the Blood Supply in Latin America (2005)Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. (2009)Prevention of transfusion-transmitted infections (2019)Transfusion-transmitted infections (2007)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevalence and Trend of Major Transfusion-Transmissible Infections among Blood Donors in Western China, 2005 through 2010 (2014)Access to safe blood in low-income and middle-income countries: lessons from India (2017)Dynamic temporary blood facility location-allocation during and post-disaster periods (2017)
this work references cited by second hop

References

  • 2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited
  • 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
  • 2000Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996287 cited
  • 2009Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion221 cited
  • 2009The risk of transfusion‐transmitted infections in sub‐Saharan Africa160 cited
  • 2011Screening donated blood for transfusion-transmissible infections, recommendations148 cited
  • 2003Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.126 cited
  • 2005Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus107 cited
  • 2009Relative safety of first‐time volunteer and replacement donors in West Africa93 cited
  • 2005Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first‐time blood donors in São Paulo, Brazil71 cited

Cited by

  • 2013Can family or replacement blood donors become regular volunteer donors?58 cited
  • 2012Analysis of donor deferral at three blood centers in Brazil

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

50 cited
  • 2012The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): Twenty Years of Research to Advance Blood Product Safety and Availability50 cited
  • 2012Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 201046 cited
  • 2012Prevalence, incidence, and residual risks for transfusion‐transmitted human immunodeficiency virus T ypes 1 and 2 infection among C hinese blood donors36 cited
  • 2020Sero-prevalence ABO and Rh blood groups and their associated Transfusion-Transmissible Infections among Blood Donors in the Central Region of Saudi Arabia36 cited
  • 2013Undisclosed human immunodeficiency virus risk factors identified through a computer‐based questionnaire program among blood donors in B razil34 cited
  • 2016The infectious risks in blood transfusion as of today – A no black and white situation31 cited
  • 2021Seroprevalence of Transfusion-Transmitted Infections among Voluntary and Replacement Blood Donors at the Peshawar Regional Blood Centre, Khyber Pakhtunkhwa, Pakistan29 cited
  • 2020Prevalence and Association of Transfusion Transmitted Infections with ABO and Rh Blood Groups among Blood Donors at the National Blood Bank, Amman, Jordan26 cited
  • 2022Prevalence and Association of Transfusion Transmitted Infections with ABO and Rh Blood Groups among Blood Donors in the Western Region of Saudi Arabia: A 7-Year Retrospective Analysis25 cited
  • 2017Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil25 cited
  • 2013Human immunodeficiency virus transfusion transmission despite nucleic acid testing24 cited
  • 2014Changes in the prevalence, incidence and residual risk for HIV and hepatitis C virus in Southern Brazilian blood donors since the implementation of NAT screening23 cited
  • 2014Estimating the residual risk for HIV , HCV and HBV in different types of platelet concentrates in Germany20 cited
  • 2012Relationship between social capital and test seeking among blood donors in Brazil16 cited